SCHEMBL7044304

SCHEMBL7044304

Oc1ccc2ccccc2c1-c1nc(-c2ccc(C(F)(F)F)cn2)no1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.50
CHUK O15111 1/20 0.44
TXNRD1 Q16881 1/20 0.44
NOX4 Q9NPH5 1/20 0.44
MAPT P10636 4/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TP53 P04637 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HSD17B10 Q99714 2/20 0.40
NPC1 O15118 2/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
HDAC4 P56524 2/20 0.36
HDAC1 Q13547 2/20 0.36
S1PR1 P21453 3/20 0.36
STAT3 P40763 2/20 0.36
CNR2 P34972 1/20 0.36
NPSR1 Q6W5P4 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049003 0.81 SMN1; SMN2 (0.62) CASP3CHUKTXNRD1NOX4MAPT
SCHEMBL7051693 0.80 CHUK (0.68) CASP3CHUKTXNRD1NOX4MAPT
SCHEMBL6449108 0.80 MAPT (0.39) CASP3MAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL6453925 0.80 CHUK (0.46) CASP3CHUKTXNRD1NOX4MAPT
SCHEMBL6451167 0.79 TP53 (0.63) MAPTKDM4EALDH1A1TP53SMN1; SMN2
SCHEMBL7048686 0.77 CASP3 (0.52) CASP3CHUKTXNRD1NOX4NPC1
SCHEMBL7153588 0.75 CASP3 (0.53) CASP3CHUKTXNRD1NOX4KDM4E
SCHEMBL6450097 0.73 SMN1; SMN2 (0.59) CASP3CHUKTXNRD1NOX4MAPT
SCHEMBL6449975 0.72 S1PR1 (0.50) CASP3CHUKTXNRD1NOX4MAPT
SCHEMBL6448883 0.71 CASP3 (0.48) CASP3CHUKTXNRD1NOX4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004110351-A2 HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS ANADYS PHARMACEUTICALS, INC. (US) 2004-12-23 WO disclosed